UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 247

Sortiert nach

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

The lancet oncology, 2015-10, Vol.16 (13), p.1389-1398

2015

Volltextzugriff (PDF)

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

Breast cancer research and treatment, 2010-08, Vol.123 (1), p.9-24

2010

Volltextzugriff (PDF)

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

Current medical research and opinion, 2005-09, Vol.21 (9), p.1453-1460

2005

Volltextzugriff (PDF)

Obesity and health-related quality of life: a cross-sectional analysis of the US population

International Journal of Obesity, 2003-10, Vol.27 (10), p.1227-1232

2003

Volltextzugriff (PDF)

Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

Annals of oncology, 2014-03, Vol.25 (3), p.700-706

2014

Volltextzugriff (PDF)

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

Annals of oncology, 2014-07, Vol.25 (7), p.1428-1436

2014

Volltextzugriff (PDF)

Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study

European journal of cancer (1990), 2022-07, Vol.169, p.188-197

2022

Volltextzugriff (PDF)

Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis

Journal of gastrointestinal cancer, 2023-12, Vol.54 (4), p.1031-1045

2023

Volltextzugriff (PDF)

Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis

International journal of colorectal disease, 2023-01, Vol.38 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Adherence with colorectal cancer screening guidelines: a review

Preventive medicine, 2004-05, Vol.38 (5), p.536-550

2004

Volltextzugriff (PDF)

Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study

Gynecologic oncology, 2022-08, Vol.166 (2), p.245-253

2022

Volltextzugriff (PDF)

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer

Annals of oncology, 2019-06, Vol.30 (6), p.1019-1019

2019

Volltextzugriff (PDF)

Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer

Cancer treatment and research communications, 2023-01, Vol.36, p.100712-100712, Article 100712

2023

Volltextzugriff (PDF)

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer

Annals of oncology, 2011-12, Vol.22 (12), p.2582-2590

2011

Volltextzugriff (PDF)

Primary culture of tracheal aspirate-derived human airway basal stem cells

STAR protocols, 2022-06, Vol.3 (2), p.101390-101390, Article 101390

2022

Volltextzugriff (PDF)

Assessing the Economic Burden of Adverse Effects (AES) Associated with Metastatic Melanoma (MM) Treatments in Germany

Value in health, 2014-05, Vol.17 (3), p.A80-A80

2014

Volltextzugriff (PDF)

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

British journal of cancer, 2008-09, Vol.99 (5), p.711-715

2008

Volltextzugriff (PDF)

Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey

Cancer epidemiology, biomarkers & prevention, 2005-02, Vol.14 (2), p.409-416

2005

Volltextzugriff (PDF)

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

British journal of cancer, 2008-11, Vol.99 (10), p.1572-1578

2008

Volltextzugriff (PDF)

Adjusting for Treatment Crossover in A Trametinib Metastatic Melanoma Rct: Identifying the Appropriate Method

Value in health, 2014-11, Vol.17 (7), p.A577-A577

2014

Volltextzugriff (PDF)

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment

Breast cancer research and treatment, 2009-10, Vol.117 (3), p.577-589

2009

Volltextzugriff (PDF)

Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization

Osteoporosis international, 2008-10, Vol.19 (10), p.1421-1429

2008

Volltextzugriff (PDF)

Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e371-387

2013

Volltextzugriff (PDF)

Economic Burden of Adverse Effects Associated with Metastatic Melanoma (MM) Treatments in the United Kingdom

Value in health, 2014-05, Vol.17 (3), p.A81-A81

2014

Volltextzugriff (PDF)

Cost Burden of Adverse Effects Associated with Metastatic Melanoma (MM) Therapies in Australia

Value in health, 2014-05, Vol.17 (3), p.A81-A81

2014

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(227)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(101)
Humans
(87)
Female
(60)
Male
(47)
Middle Aged
(43)
Oncology
(42)
Biological And Medical Sciences
(35)
Medical Sciences
(33)
Adult
(27)
Aged
(26)
Internal Medicine
(21)
Animals
(19)
United States
(19)
Chemotherapy
(16)
Tumors
(16)
Quality Of Life
(15)
Retrospective Studies
(14)
Antineoplastic Agents - Therapeutic Use
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

Obesity and health-related quality of life: a cross-sectional analysis of the US population

Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study

Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis

Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis

Adherence with colorectal cancer screening guidelines: a review

Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer

Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer

Primary culture of tracheal aspirate-derived human airway basal stem cells

Assessing the Economic Burden of Adverse Effects (AES) Associated with Metastatic Melanoma (MM) Treatments in Germany

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

Adjusting for Treatment Crossover in A Trametinib Metastatic Melanoma Rct: Identifying the Appropriate Method

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment

Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization

Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada

Economic Burden of Adverse Effects Associated with Metastatic Melanoma (MM) Treatments in the United Kingdom

Cost Burden of Adverse Effects Associated with Metastatic Melanoma (MM) Therapies in Australia

Suchergebnisse filtern